Circular RNA circ_0048764 promotes the development of breast cancer by regulating microRNA-1296-5p/tripartite motif containing 14 axis

References

• Guanghui R, Xiaoyan H, Shuyi Y, et al. An efficient or methodical review of immunotherapy against breast cancer. J Biochem Mol Toxicol. 2019 Aug;33(8):e22339.
   PubMed Web of Science ®Google Scholar
• Yeo SK, Guan JL. Breast cancer: multiple subtypes within a Tumor? Trends Cancer. 2017 Nov;3(11):753–760.
   PubMed Web of Science ®Google Scholar
• Liang Y, Zhang H, Song X, et al. Metastatic heterogeneity of breast cancer: molecular mechanism and potential therapeutic targets. Semin Cancer Biol. 2020 Feb;60:14–27.
   PubMed Web of Science ®Google Scholar
• Li Z, Chen Z, Hu G, et al. Roles of circular RNA in breast cancer: present and future. Am J Transl Res. 2019 Jul 15;11(7):3945–3954.
   PubMed Web of Science ®Google Scholar
• Chen LL, Yang L. Regulation of circRNA biogenesis. RNA Biol. 2015;12(4):381–388.
   PubMed Web of Science ®Google Scholar
• Vo JN, Cieslik M, Zhang Y, et al. The landscape of circular RNA in cancer. Cell. 2019 Feb 7;176(4):869–881.e13.
   PubMed Web of Science ®Google Scholar
• Liang G, Ling Y, Mehrpour M, et al. Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression. Mol Cancer. 2020 Mar 25;19(1):65.
   PubMed Web of Science ®Google Scholar
• Sang Y, Chen B, Song X, et al. circRNA_0025202 regulates tamoxifen sensitivity and tumor progression via regulating the miR-182-5p/FOXO3a axis in breast cancer. Mol Ther. 2019 Sep 4;27(9):1638–1652.
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhou Y, Liang G, et al. Circular RNA hsa_circ_001783 regulates breast cancer progression via sponging miR-200c-3p. Cell Death Dis. 2019 Jan 22;10(2):55.
   PubMed Web of Science ®Google Scholar
• Correia de Sousa M, Gjorgjieva M, Dolicka D, et al. Deciphering miRNAs’ action through miRNA editing. Int J Mol Sci. 2019 Dec 11;20(24):6249.
   PubMed Web of Science ®Google Scholar
• Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011 Aug 5;146(3):353–358.
   PubMed Web of Science ®Google Scholar
• Yin Z, Wang W, Qu G, et al. MiRNA-96-5p impacts the progression of breast cancer through targeting FOXO3. Thorac Cancer. 2020 Apr;11(4):956–963.
   PubMed Web of Science ®Google Scholar
• Niu XY, Zhang ZQ, Ma PL. MiRNA-221-5p promotes breast cancer progression by regulating E-cadherin expression. Eur Rev Med Pharmacol Sci. 2019 Aug;23(16):6983–6990.
   PubMed Web of Science ®Google Scholar
• Xu Z, Yan Y, Zeng S, et al. Circular RNAs: clinical relevance in cancer. Oncotarget. 2017 Dec 1;9(1):1444–1460.
   PubMedGoogle Scholar
• Meng QH, Li Y, Kong C, et al. Circ_0000388 exerts oncogenic function in cervical cancer cells by regulating miR-337-3p/TCF12 axis. Cancer Biother Radiopharm. 2021 Feb;36(1):58–69.
   PubMed Web of Science ®Google Scholar
• Yang X, Wang J, Li H, et al. Downregulation of hsa_circ_0026123 suppresses ovarian cancer cell metastasis and proliferation through the miR-124-3p/EZH2 signaling pathway. Int J Mol Med. 2021 Feb;47(2):668–676.
   PubMed Web of Science ®Google Scholar
• Cao L, Wang M, Dong Y, et al. Circular RNA circRNF20 promotes breast cancer tumorigenesis and Warburg effect through miR-487a/HIF-1α/HK2. Cell Death Dis. 2020 Feb 24;11(2):145.
   PubMed Web of Science ®Google Scholar
• Liang HF, Zhang XZ, Liu BG, et al. Circular RNA circ-ABCB10 promotes breast cancer proliferation and progression through sponging miR-1271. Am J Cancer Res. 2017 Jul 1;7(7):1566–1576.
   PubMed Web of Science ®Google Scholar
• Liang Y, Song X, Li Y, et al. circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer. Oncogene. 2019 Oct;38(42):6850–6866.
   PubMed Web of Science ®Google Scholar
• Chen G, He M, Yin Y, et al. miR-1296-5p decreases ERBB2 expression to inhibit the cell proliferation in ERBB2-positive breast cancer. Cancer Cell Int. 2017 Oct 24;17(1):95.
   PubMedGoogle Scholar
• Zhang Y, Zhang XO, Chen T, et al. Circular intronic long noncoding RNAs. Mol Cell. 2013 Sep 26;51(6):792–806.
   PubMed Web of Science ®Google Scholar
• Dong W, Dai ZH, Liu FC, et al. The RNA-binding protein RBM3 promotes cell proliferation in hepatocellular carcinoma by regulating circular RNA SCD-circRNA 2 production. EBioMedicine. 2019 Jul;45:155–167.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Lu G, Luo Z, et al. CircRNA circ_0067934 promotes tumor growth and metastasis in hepatocellular carcinoma through regulation of miR-1324/FZD5/Wnt/β-catenin axis. Biochem Biophys Res Commun. 2018 Mar 4;497(2):626–632.
   PubMed Web of Science ®Google Scholar
• Yao Y, Li X, Cheng L, et al. Circular RNA FAT atypical cadherin 1 (circFAT1)/microRNA-525-5p/spindle and kinetochore-associated complex subunit 1 (SKA1) axis regulates oxaliplatin resistance in breast cancer by activating the notch and Wnt signaling pathway. Bioengineered. 2021 Dec;12(1):4032–4043.
   PubMed Web of Science ®Google Scholar
• Zhong W, Bao L, Yuan Y, et al. CircRASSF2 acts as a prognostic factor and promotes breast cancer progression by modulating miR-1205/HOXA1 axis. Bioengineered. 2021;12(1):3014–3028.
   PubMed Web of Science ®Google Scholar
• Zhang X, Xu X, Ge G, et al. miR-498 inhibits the growth and metastasis of liver cancer by targeting ZEB2. Oncol Rep. 2019 Mar;41(3):1638–1648.
   PubMed Web of Science ®Google Scholar
• Li P, Xu T, Zhou X, et al. Downregulation of miRNA-141 in breast cancer cells is associated with cell migration and invasion: involvement of ANP32E targeting. Cancer Med. 2017 Mar;6(3):662–672.
   PubMed Web of Science ®Google Scholar
• Jiang H, Cheng L, Hu P, et al. MicroRNA-663b mediates TAM resistance in breast cancer by modulating TP73 expression. Mol Med Rep. 2018 Jul;18(1):1120–1126.
   PubMed Web of Science ®Google Scholar
• Zhao B, Song X, Guan H. CircACAP2 promotes breast cancer proliferation and metastasis by targeting miR-29a/b-3p-COL5A1 axis. Life Sci. 2020 Mar 1;244:117179.
   PubMed Web of Science ®Google Scholar
• Pan G, Mao A, Liu J, et al. RNA hsa_circ_0061825 (circ-TFF1) contributes to breast cancer progression through targeting miR-326/TFF1 signalling. Cell Prolif. 2020 Feb;53(2):e12720.
   PubMed Web of Science ®Google Scholar
• Jia Y, Zhao LM, Bai HY, et al. The tumor-suppressive function of miR-1296-5p by targeting EGFR and CDK6 in gastric cancer. Biosci Rep. 2019 Jan 8;39(1):BSR20181556.
   PubMedGoogle Scholar
• Zang H, Li Y, Zhang X, et al. Circ_0000517 contributes to hepatocellular carcinoma progression by upregulating TXNDC5 via sponging miR-1296-5p. Cancer Manag Res. 2020 May 14;12:3457–3468.
   PubMed Web of Science ®Google Scholar
• Hu G, Pen W, Wang M. TRIM14 promotes breast cancer cell proliferation by inhibiting apoptosis. Oncol Res. 2019 Mar 29;27(4):439–447.
   PubMed Web of Science ®Google Scholar
• Xu G, Guo Y, Xu D, et al. TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway. Sci Rep. 2017 Feb 16;7(1):42411.
   PubMedGoogle Scholar
• Su X, Wang J, Chen W, et al. Overexpression of TRIM14 promotes tongue squamous cell carcinoma aggressiveness by activating the NF-κB signaling pathway. Oncotarget. 2016 Mar 1;7(9):9939–9950.
   PubMedGoogle Scholar
• Tan Z, Song L, Wu W, et al. TRIM14 promotes chemoresistance in gliomas by activating Wnt/β-catenin signaling via stabilizing Dvl2. Oncogene. 2018 Oct;37(40):5403–5415.
   PubMed Web of Science ®Google Scholar
• Shen W, Jin Z, Tong X, et al. TRIM14 promotes cell proliferation and inhibits apoptosis by suppressing PTEN in colorectal cancer. Cancer Manag Res. 2019 Jun 24;11:5725–5735.
   PubMed Web of Science ®Google Scholar